The indictment accuses the defendants of fraudulently billing healthcare insurers and prescription drug administrators more than $200 million for drugs that patients didn’t need.
In one instance, prosecutors charge that the workers’ fraudulent conduct resulted in a prescription administrator paying over $29,000 for a tube of cream to treat general wounds. In another instance, the pharmacy billed insurers for creams used by females that were issued to male patients, according to the charges.
“Motivated by greed, the defendants executed a brazen healthcare fraud conspiracy and scheme that cost health insurance plans, including those that protect the elderly, disabled, military members and veterans, millions of dollars,” Attorney Jay Town of the U.S. Justice Department said, according to WSFA. “Their scheme deprived health insurance plans of money that could have gone to assist patients with real medical needs.”
More articles on pharmacy:
Insys execs guilty of opioid racketeering scheme
Walgreens shaking up C-suite
Generic drugmakers could thrive in a recession, Moody’s says
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.